Smart diagnostics.
Built for modern labs.

End‑to‑end diagnostic infrastructure for
high‑throughput pathology services.

Pathology advantages

Standardise sample pathways across laboratory networks

Strengthen traceability and compliance from receipt to result

Reduce rework, repeat testing and processing errors

Increase throughput without adding operational complexity

Diagnostic infrastructure partner for pathology

Efficiently sourced biosamples are critical to pathology service performance. How samples are collected, transported and processed has a direct impact on turnaround times, compliance and result reliability.

A connected pathway for pathology services

A consistent, traceable workflow that supports scale, speed and compliance across pathology operations.

1
1

Choose off-the-shelf, or protocol-specific kit configuration

2
2

Patient receives kit at home or in-clinic

3
3

Sample collected using standardised instructions

4
4

Laboratory receives and processes results

5
5

Patient confirmation recorded

6
6

Aggregated insights returned to sponsor and trial teams

Built for high‑volume pathology workflows

RDi partners with NHS Pathology Hubs, hospital Trusts and private laboratories to deliver end‑to‑end diagnostic kits, componentry and infrastructure that support high‑volume, high‑complexity pathology services.

From standardised sample collection and compliant logistics through to digital traceability, lab integration and reporting, our connected platform reduces variability and supports operational performance across networks.

Download our Pathology brochure

Pathology A4 Brochure Mock
CURA Image
CURA Logo

Pathology sample insights enabled with +CURA

Digital infrastructure that underpins modern pathology workflows.

+CURA is RDi’s real-time sample tracking and traceability platform, providing laboratories with end-to-end visibility across the diagnostic pathway.

Designed to integrate with existing LIMS, EPR and laboratory systems, +CURA supports quality management, audit readiness and operational oversight through a centralised dashboard and reporting environment.

Pathways built
for pathology
teams under
pressure

Frequently asked questions

Yes. RDi’s kits and digital infrastructure are designed to work alongside existing laboratory environments.

+CURA integrates with LIMS and wider lab systems to support sample tracking, traceability and reporting, without requiring changes to your core laboratory setup.

Every kit and sample is uniquely identified and digitally tracked across the pathway.
From sample registration and transport through laboratory receipt and processing, +CURA maintains a clear, auditable chain of custody to support governance, quality management and audit requirements.
This visibility reduces the risk of mislabelling, sample loss and undocumented hand offs.

RDi manages end to end fulfilment and compliant logistics to ensure samples move efficiently from collection to laboratory receipt.
Standardised packaging, integrated tracking and coordinated transport reduce delays, minimise handling errors and support faster, more predictable processing within pathology services.

Pathology services increasingly operate across regional hubs, satellite sites and partner organisations.
RDi supports these models through standardised kits, consistent logistics and centralised digital traceability, enabling samples from multiple locations to move through a single, governed pathway.
This helps pathology networks maintain consistency, visibility and performance at scale without increasing operational complexity.

RDi designs and manages diagnostic kits with consistency as a priority. Standardised components, controlled assembly and compliant logistics help minimise variation and support reliable processing across high volume pathology workflows.

In clinical and laboratory settings, RDi supplies kits and components designed to be intuitive and align with existing pathology workflows, requiring no specialist retraining beyond standard laboratory procedures.
For at home services, self-sampling kits are designed for ease of use by non clinical users and are supported by clear instructions and optional multilingual guidance to help ensure samples are collected correctly.

Yes. RDi’s pathology kits and components are manufactured in line with ISO 13485 and ISO 17025 aligned processes.
Kits are MHRA compliant, CE marked and ID registered where applicable, supporting secure, compliant use across pathology services without compromise.

 

Thank you for your enquiry

The RDi Team will be in contact shortly